A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Name: A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
License: Public Domain

Astellas Pharma Europe B.V.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

chronic-kidney-disease type-2-diabetes

chronic kidney disease, type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 668935
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.